@benelong
Brilliant mate. Ive stated before that MPC's are like millions of homing cells that find the damaged tissue. They just know where to go.
Attaching molecules to the tracking devices has huge potential.
Hence the partnership with Cartherics for cancer. They too need Mesoblast as well.
NEW YORK and MELBOURNE, Australia, May 29, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR-T cells armed with multiple targeting receptors for use in solid cancers. Off the shelf CAR-T therapies have the potential to reduce costs dramatically and open up this very effective treatment to millions of cancer patients across the world. The initial targets are relapsed ovarian and gastric cancers. Mesoblast and Cartherics will jointly own the intellectual property produced using their combined technologies.
https://globenewswire.com/news-rele...-based-Immunotherapies-for-Solid-Cancers.html
- Forums
- ASX - By Stock
- MSB
- MPCs as a commodity. Bleeding obvious.
MSB
mesoblast limited
Add to My Watchlist
0.93%
!
$1.63

MPCs as a commodity. Bleeding obvious., page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
0.015(0.93%) |
Mkt cap ! $2.082B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $6.975M | 4.265M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 707 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 7320 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 707 | 1.630 |
3 | 51200 | 1.625 |
15 | 159486 | 1.620 |
3 | 75310 | 1.615 |
11 | 90509 | 1.610 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 7000 | 1 |
1.640 | 17668 | 3 |
1.645 | 20972 | 3 |
1.650 | 37309 | 4 |
1.655 | 45000 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online